Joanna Metzner-Sadurski: Better Systems for Patients Start With Advocacy

Shernan Holtan: An Important 5 Minute Survey on AI in Medicine

Douglas Flora։ What Patients Count: What We Measure in Cancer Care - And What We Should.

Top 10 OncoGrants This Week (Feb 2026): Summer Research, Pilot Awards, and Quality-of-Life Funding

Julie Gralow: A Small Gift, Big ASCO Pride

Oncology News, Insights, Stories by OncoDaily

Princess Dina Mired
Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Valentine's Day - OncoDaily
Stories

Write to the One You Love: A Valentine’s Invitation from OncoDaily 2026

OncoThon 2026
OncoDaily Pulse

OncoThon 2026: From Global Awareness to Collective Action in Cancer Care

Advancing Access to Radiotherapy in Low- and Middle-Income Countries

10 Must-Read Posts in Immuno-Oncology This Week

10 Must Read Posts In GI Oncology This Week

Does Microwaved Food Cause Cancer: Separating Myths from Scientific Facts

Richard Sullivan: England's New National Cancer Plan

Vivek Subbiah and Razelle Kurzrock: Transforming How Rare and Ultra-Rare Cancers Are Recognized and Treated

A Historic Commitment Transforming the Future of Cancer Care - Dana-Farber Cancer Institute

OncoThon 2026
Advances in The Immunotherapy of Cold Tumors
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Erick Mahatara

Erick Mahatara: Prevention Does Not Start in Policy Rooms. It Starts With Us.

Gustavo Viani: FAPERJ Approves Digital Twin Project for Proton Therapy in Choroidal Melanoma

Guru Sonpavde: Precision Oncology for Urologic Cancers

Wafaa M Rashed: If Africa Does Not Lead in Shaping the Future of Genomics, Someone Else Will

Shaheenah Dawood: Excellent Perspective on the Current Challenges With ADC's

Faizan Bashir: A Child With High-Grade B-cell PTLD Confined to the Kidney Allograft

Aemish Fatima: Child Life Services and Its Impact on Pediatric Oncology Patients and Their Parents

FDA Approvals
Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

New Hope for NUT Carcinoma: FDA Grants Orphan Drug Status to ZEN-3694

OncoDaily 100
100 Most Influential CEOs

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

British Society of Haematology Supportive Care Specialist Interest Group (SIG) Prioritisation Workshop

British Society of Haematology

25 Feb
British Society of Haematology

Escalation or De-Escalation? Strategies in HER2+ Breast Cancer Treatment

Sharing Progress in Cancer Care

23 Apr
Breast Cancer Treatment

38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026)

European Organisation for Research and Treatment of Cancer

18 Nov
EORTC-NCI-AACR

Clinical Trial Statistics for Non-Statisticians Workshop

European Organisation for Research and Treatment of Cancer

09 Jun
Clinical Trial Statistics

15th European Breast Cancer Conference (EBCC-15)

European Organisation for Research and Treatment of Cancer

25 Mar
Breast Cancer Conference

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

10 Posts Not to Miss from ESMO

OncoDaily TV
Princess Dina Mired

Global Health Dialogues with Princess Dina Mired: Dr. Gevorg Tamamyan

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

Global Health Dialogues with Princess Dina Mired: HE Dr. Maggie De Block

minister

When Minister is also your treating Doctor – Hosams Abu Meri

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Dr. Navid Madani

Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Mohamed Osman

ONCOFFEE: Mohamed Osman – Building a Research Career from Egypt to New York

Not To Miss
OncoDaily Weekly

Oncology This Week: OncoDaily Weekly Feb 2-8, 2026

Exciting News: OncoDaily's Managing Editor Dr Elen Baloyan Releases Her 1st Mini-EP

World Cancer Day: A Global Call to Awareness and Action 2026, Part 3

Gevorg Tamamyan: The Power of a TEAM

World Cancer Day: A Global Call to Awareness and Action 2026, Part 2

World Cancer Day: A Global Call to Awareness and Action 2026, Part 1

Highlights from ELLOK Annual Conference 2026: Health Literacy in Focus: Opportunities and Challenges

OncoGrants
Moffitt–PHSU Oncology Pilot Research Projects

Moffitt–PHSU Oncology Pilot Research Projects (CPACH) 2026

Cancer Consortium Oncology Pilot Awards

Cancer Consortium Oncology Pilot Awards 2026

Blood Cancer Canada Oncology Quality of Life Research Grant

Blood Cancer Canada Oncology Quality of Life Research Grant 2026

Hecht Foundation Disruptive Innovation Grants

Hecht Foundation Disruptive Innovation Grants

NETRF

NETRF Neuroendocrine Tumor Research Grants

VeloSano Collaborative Oncology Research Grants

VeloSano Collaborative Oncology Research Grants 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Khushali Jhaveri

Khushali Jhaveri

Oncologists Location Indianapolis, USA
Rachna Shroff

Rachna Shroff

Oncologists Location Tucson, USA
Tezer Kutluk

M. Tezer Kutluk

Oncologists Location Ankara, Türkiye
Sarkis Meterissian

Sarkis Meterissian

Oncologists Location Montreal, Canada
Roupen Odabashian

Roupen Odabashian

Oncologists Location Detroit, USA
Gabriëlle van Ramshorst

Gabriëlle van Ramshorst

Oncologists Location Ghent, Belgium
Ana Filipa Martins Ferreira Varges Gomes

Ana Filipa Martins Ferreira Varges Gomes

Oncologists Location Portimão, Portugal
Zulfiquer Otty

Zulfiquer Otty

Oncologists Location Townsville, Australia

Oncology Drugs
GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

GSK5764227 (HS-20093): Clinical Development of a Next-Generation B7-H3 Directed Antibody–Drug Conjugate

Daraxonrasib (RMC-6236): Clinical Development of a RAS(ON) Inhibitor Advancing Precision Therapy in RAS-Driven Solid Tumors

Daraxonrasib (RMC-6236): A New Targeted Treatment Being Studied for RAS-Driven Cancers

Anbenitamab (KN026): A Patient-Friendly Guide to a New HER2-Targeted Treatment

Anbenitamab (KN026): A Deep Dive Into a Bispecific HER2 Antibody Redefining Targeted Therapy

Iza-Bren (EGFR×HER3 ADC): A Patient-Friendly Guide To A New Cancer Treatment

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
ARTS Trial

ARTS Trial: Adjuvant Aumolertinib in Resected EGFR-Mutated NSCLC

CATNON Trial

CATNON Final Analysis: Defining the Role of Adjuvant Temozolomide in IDH-Mutant Grade 3 Astrocytoma

JUPITER-06

JUPITER-06 Final Overall Survival and Genomic Biomarker Analysis in Advanced ESCC

JCOG0603

JCOG0603 Long-Term Results: Adjuvant mFOLFOX6 After Hepatectomy in Resectable Colorectal Liver Metastases

Nous-209 vaccine

New Paper Alert: Nous-209 Neoantigen Vaccine for Cancer Interception in Lynch Syndrome

LARA Trial

LARA Trial: Pembrolizumab–Lenvatinib in Recurrent Gynecologic Clear Cell Carcinoma

OncoDaily Medical Journal

Radiation Oncology

10.69690/ODMJ-018-3101-6699

Comparative Evaluation of DIR-Based Auto-Adaptive, Manual, and Semi-Automated Contouring for Pelvic OARs in Cervical Cancer Adaptive Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6997

Validity of 18F FDG-PET/CT in the Detection of Bone Marrow Disease in Hodgkin's and Non-Hodgkin's Lymphoma
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7103

Dosimetric Comparison of 5-, 7-, and 9-Field SIB-IMRT Plans in Prostate Cancer Using 100% Isodose-Based Target Evaluation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6652

Radiation‐induced Lung Toxicity: A Crucial Problem in Thoracic Radiotherapy
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7089

Hippocampus Sparing for Patients Undergoing Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma in Morocco: A Dosimetric Study
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6686

Optimizing Quality of Life in Cervical Cancer Survivors: A Comparative Study of Vaginal Doses Delivered Using Three HDR Brachytherapy Applicators
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-6503

Assessment of MOSFET Detectors in In-Vivo Dosimetry for VMAT Total Body Irradiation
Abstracts

Radiation Oncology

10.69690/ODMJ-018-3101-7028

A Novel Evaluation Formula for Plan Quality in Conventional Fractionated and Stereotactic Radiotherapy: Nabaa Efficiency Index (NEI)
Abstracts